- Can we slow down progressiobn of diabetic nephropathy by the inhibition of advaced glycation endproducts?2004 | First Faculty of Medicine
- Advanced glycation endproduct and advanced oxidation protein product in hemodialysed patientsPublication without faculty affiliation
- Pathogenesis of diabetic complications2009 | First Faculty of Medicine
- Pathogenesis of diabetic complications2009 | Publication without faculty affiliation
- Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease2013 | Second Faculty of Medicine
- Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus2013 | First Faculty of Medicine, Faculty of Physical Education and Sport
- The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker?2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Pregnancy-associated plasma protein A (PAPP-A) and soluble receptor for advanced glycation end products (sRAGE) - intra- and inter-individual variability in chronic hemodialysis patients2012 | First Faculty of Medicine
- Advanced glycation end products in myocardial reperfusion injury2012 | First Faculty of Medicine
- Low maternal serum matrix metalloproteinase (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory response2010 | First Faculty of Medicine
- Type 2 diabetes mellitus and bone2013 | First Faculty of Medicine
- Receptor for advanced glycation end products (RAGE) and glyoxalase I gene polymorphisms in pathological pregnancy2012 | First Faculty of Medicine
- Cerebrolysin inhibits lipid peroxidation induced by insuline hypoglycemia in the brain and heart of mice2003 | Third Faculty of Medicine
